News tagged with fda approval
Related topics: drug , food and drug administration
Antibiotic combination defeats extensively drug-resistant TB
A combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating extensively drug resistant tuberculosis (XDR-TB), the most deadly form of the ...
Medicine & Health / Medical research
Feb 26, 2009 |
5 / 5 (8) |
0
Research into stem cells of adults stirs hopes
A year after President Barack Obama eased restrictions on research into embryonic stem cells and pledged billions in new stimulus money for it, researchers are almost giddy with enthusiasm about progress in the field. They're ...
Medicine & Health / Medical research
Apr 28, 2010 |
5 / 5 (3) |
1
FDA reversal OKs morphine painkiller for dying
(AP) -- A liquid morphine painkiller given by family caregivers to dying patients can remain on the market, federal regulators have decided after hearing protests over their decision to remove it. The Food and Drug Administration ...
Medicine & Health / Medications
Apr 09, 2009 |
3.3 / 5 (3) |
2
Scientist urges government ruling on genetically engineered salmon
A Purdue University scientist is urging federal officials to decide whether genetically engineered salmon would be allowed for U.S. consumption and arguing that not doing so may set back scientific efforts to increase food ...
Aug 06, 2011 |
5 / 5 (2) |
1
Speedy generic approval may not benefit consumers as much as expected, model shows
Faster approval times for generic drugs will get them into consumers' hands quicker, but may not make the price any better, a pricing and marketing researcher has found.
Medicine & Health / Medications
Feb 08, 2011 |
5 / 5 (1) |
0
US takes aim at purported sex disease 'cures'
The US government said Tuesday it is taking steps to remove from the market a host of online products that promise to cure HIV, herpes, chlamydia and other sexually transmitted diseases.
Medicine & Health / Medications
May 03, 2011 |
5 / 5 (1) |
1
Bill revision could mean money for NJ drug company
(AP) -- A billion-dollar "technical revision" added to a patent bill passed by the House last week could provide huge financial benefits to one pharmaceutical company and a law firm.
Jun 30, 2011 |
5 / 5 (1) |
0
